FDC Ltd share Price Today

Pharmaceuticals company FDC announced Q4FY24 & FY24 results:

Operating Revenue

FDC Limited reported an increase in operating revenue, with a 6.3% growth in the fourth quarter (Q4FY24) and an 8.9% growth for the full fiscal year (FY24) compared to the previous corresponding periods.

EBITDAs and Profitability

The company's EBITDA grew significantly, with an increase of 15.1% for Q4 and 34.9% for the full year. Profit after tax (PAT) for Q4FY24 was reported at Rs 46 crore, showing a growth of 50.9%, and Rs 305 crore for FY24, marking an increase of 57.4% year-over-year.

Earnings Per Share (EPS)

Earnings Per Share saw a substantial rise for both Q4FY24 and FY24, increasing by 53.7% and 59.3% respectively, indicating a strong performance by the company.

Business-wise Sales Breakdown

Domestic formulations showed growth, particularly driven by flagship brands such as Electral, Zifi, Enerzal, and Zifi-O.

US and Emerging Markets formulating businesses are also trending positively, although US formulations saw a slight decrease in the fourth quarter.

API sales exhibited a significant growth of 24.0% for the fourth quarter and an 11.9% increase for the fiscal year.

Geographical Revenue Contributions

Revenue from international operations, specifically in the US and Rest of the World (ROW) markets, has been notable, with consolidated revenue showing a 12% increase. The export formulations accounted for 15% of the total consolidated revenue.

Result PDF